D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 98 Citations 39,912 382 World Ranking 4115 National Ranking 121

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Gene
  • Internal medicine

Pieter Wesseling mainly focuses on Pathology, Glioma, Cancer research, Immunology and Cancer. His specific area of interest is Pathology, where he studies Brain tumor. His work on Diffuse Glioma as part of general Glioma study is frequently linked to Clinical neurology, bridging the gap between disciplines.

Pieter Wesseling interconnects DNA methylation, Primary tumor, DNA repair and Gene expression profiling in the investigation of issues within Cancer research. The study incorporates disciplines such as Platelet and Lung cancer in addition to Cancer. His Temozolomide research incorporates elements of Hazard ratio, Phenotype and Intention-to-treat analysis.

His most cited work include:

  • Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial (4693 citations)
  • DNA methylation-based classification of central nervous system tumours (733 citations)
  • DNA methylation-based classification of central nervous system tumours (733 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Pathology, Glioma, Cancer research, Internal medicine and Oncology. His Pathology research focuses on subjects like Melanoma, which are linked to Metastasis. His Glioma research includes themes of DNA methylation and IDH1.

His Cancer research study integrates concerns from other disciplines, such as Mutation, Immunology and Pharmacology. All of his Internal medicine and Cancer and Breast cancer investigations are sub-components of the entire Internal medicine study. Pieter Wesseling combines subjects such as Hazard ratio and Radiation therapy, Temozolomide with his study of Oncology.

He most often published in these fields:

  • Pathology (56.25%)
  • Glioma (47.78%)
  • Cancer research (30.04%)

What were the highlights of his more recent work (between 2016-2021)?

  • Glioma (47.78%)
  • Cancer research (30.04%)
  • Pathology (56.25%)

In recent papers he was focusing on the following fields of study:

Pieter Wesseling mainly investigates Glioma, Cancer research, Pathology, Internal medicine and Oncology. His Glioma research integrates issues from IDH1, Isocitrate dehydrogenase and DNA methylation. His research integrates issues of Cancer, Mutation, Gene, Somatic cell and Platelet in his study of Cancer research.

Pieter Wesseling works mostly in the field of Pathology, limiting it down to concerns involving Magnetic resonance imaging and, occasionally, Positron emission tomography. His study in Internal medicine concentrates on Radiation therapy, Hazard ratio, Temozolomide and Disease. His biological study spans a wide range of topics, including O-6-methylguanine-DNA methyltransferase and Cell growth.

Between 2016 and 2021, his most popular works were:

  • DNA methylation-based classification of central nervous system tumours (733 citations)
  • DNA methylation-based classification of central nervous system tumours (733 citations)
  • WHO 2016 Classification of gliomas (183 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Gene
  • Internal medicine

Pieter Wesseling focuses on Glioma, Cancer research, Internal medicine, Oncology and Pathology. Glioma is closely attributed to Ependymoma in his research. He has researched Cancer research in several fields, including Cancer, Platelet, Immunology, IDH1 and Biomarker.

Pieter Wesseling focuses mostly in the field of Internal medicine, narrowing it down to matters related to Epigenetics and, in some cases, MAPK/ERK pathway, PI3K/AKT/mTOR pathway, Tumor suppressor gene and Signal transduction. As part of the same scientific family, Pieter Wesseling usually focuses on Pathology, concentrating on Neuroscience and intersecting with MEDLINE. Pieter Wesseling has included themes like Hazard ratio, Chemotherapy, Performance status and Intention-to-treat analysis in his Radiation therapy study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Roger Stupp;Monika E. Hegi;Warren P. Mason;Martin J. van den Bent.
Lancet Oncology (2009)

7623 Citations

Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma.

Genevieve Schindler;David Capper;David Capper;Jochen Meyer;Wibke Janzarik.
Acta Neuropathologica (2011)

1084 Citations

DNA methylation-based classification of central nervous system tumours

David Capper;David Capper;David Capper;David T. W. Jones;Martin Sill;Volker Hovestadt.
Nature (2018)

860 Citations

Diffuse glioma growth: a guerilla war

An Claes;Albert J. Idema;Pieter Wesseling.
Acta Neuropathologica (2007)

600 Citations

International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading

David N. Louis;Arie Perry;Peter Burger;David W. Ellison.
Brain Pathology (2014)

593 Citations

The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells

Dennis Lindau;Paul Gielen;Michiel Kroesen;Pieter Wesseling;Pieter Wesseling.
Immunology (2013)

589 Citations

Overcoming the blood-brain tumor barrier for effective glioblastoma treatment

O. van Tellingen;B. Yetkin-Arik;M.C. de Gooijer;P. Wesseling;P. Wesseling.
Drug Resistance Updates (2015)

504 Citations

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

Dominik Sturm;Dominik Sturm;Brent A. Orr;Umut H. Toprak;Volker Hovestadt.
Cell (2016)

479 Citations

RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics

Myron G. Best;Nik Sol;Irsan Kooi;Jihane Tannous.
Cancer Cell (2015)

465 Citations

Germline mutation of INI1/SMARCB1 in familial schwannomatosis.

Theo J.M. Hulsebos;Astrid S. Plomp;Ruud A. Wolterman;Els C. Robanus-Maandag.
American Journal of Human Genetics (2007)

421 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Pieter Wesseling

Andreas von Deimling

Andreas von Deimling

Heidelberg University

Publications: 235

Stefan M. Pfister

Stefan M. Pfister

German Cancer Research Center

Publications: 228

Wolfgang Wick

Wolfgang Wick

German Cancer Research Center

Publications: 187

Michael Weller

Michael Weller

University of Zurich

Publications: 154

David Capper

David Capper

Humboldt-Universität zu Berlin

Publications: 152

Felix Sahm

Felix Sahm

University Hospital Heidelberg

Publications: 136

Martin J. van den Bent

Martin J. van den Bent

Erasmus University Rotterdam

Publications: 111

David T. W. Jones

David T. W. Jones

German Cancer Research Center

Publications: 105

Patrick Y. Wen

Patrick Y. Wen

Harvard University

Publications: 103

Jeremy N. Rich

Jeremy N. Rich

University of Pittsburgh

Publications: 82

Guido Reifenberger

Guido Reifenberger

Heinrich Heine University Düsseldorf

Publications: 82

Kenneth D. Aldape

Kenneth D. Aldape

Princess Margaret Cancer Centre

Publications: 80

Arie Perry

Arie Perry

University of California, San Francisco

Publications: 75

David A. Reardon

David A. Reardon

Harvard University

Publications: 75

Roger Stupp

Roger Stupp

Northwestern University

Publications: 74

Justin D. Lathia

Justin D. Lathia

Cleveland Clinic Lerner College of Medicine

Publications: 74

Something went wrong. Please try again later.